• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    IMAC Holdings Reports Preliminary Fourth Quarter and Year End 2021 Financial Results and Corporate Update

    3/31/22 9:00:00 AM ET
    $IMAC
    Medical Specialities
    Health Care
    Get the next $IMAC alert in real time by email

    Revenue increased 26% for quarter and 12% annually

    BRENTWOOD, Tenn., March 31, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) ("IMAC" or the "Company"), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, today reported its preliminary financial results for the year ended December 31, 2021.

    Financial Highlights from Q4 2021:

    • $4,368,564 in revenue in Q4 21, up 26% from Q4 20 revenue of $3,463,221
    • IMAC Regeneration Center total visits for Q4 21 were 41,898, up 9.7% from 38,205 during Q4 20

    Financial Highlights from FY 2021 (all comparisons are with IMAC for the year ended December 31, 2020 unless otherwise indicated):

    • Annual revenue was $14,385,828, up 12% from $12,835,198 in 2020
    • Annual IMAC Regeneration Center patient visits increased to 168,508, up 24% from 135,488 in 2020

    Corporate Highlights in Q4 2021 and Year To Date 2022:

    • Expanded southeastern presence with acquisition of Louisiana Orthopaedic & Sports Rehab Institute (LOSI), in Baton Rouge, Louisiana.
    • Completed the second cohort and initiated the third cohort of our Phase 1 clinical study of umbilical cord-derived allogenic mesenchymal stem cells for the treatment of bradykinesia due to Parkinson's Disease.
    • Announced Dr. Ben Lerner as Chief Operating Officer, bringing decades of valuable healthcare growth experience to the executive team. Lerner previously founded and served as the CEO of Maximized Living, a national chiropractic consulting, franchising and lifestyle brand organization.
    • Launched the The Back Company Franchise, capitalizing on the success of the Company's The Back Space concept, piloted in select Walmart locations.

    "The fourth quarter of 2021 was productive. We started the quarter with the acquisition of Louisiana Orthopaedic and Spine Institute which we expect to be our largest clinic by the second half of 2022. And by the end of the quarter, we delivered 26% revenue growth on a 9.7% increase of patients visits compared to Q4 of 2020," said Jeffrey Ervin, IMAC's Chief Executive Officer.

    "During 2021, we worked diligently to reduce the Company's debt, retiring greater than $4.13 million representing over 90% of notes payable. We are well positioned for strategic growth objectives in 2022 that solidify our foundation as we continue to execute on our strategic initiatives. Today, we filed an extension to accommodate the additional time needed for our former and current auditors to complete our 10k filing."

    "Another significant accomplishment during 2021 included growing our service footprint with the launch of The Back Space retail chiropractic pilot program in select Walmart locations. We opened 10 stores in three markets as part of the pilot and recently completed The Back Company franchise to expand The Back Space presence. The infrastructure incorporates technical advancements with our consumer engagement tools as evidenced with the launch The Back mobile app, the first in the chiropractic industry to provide mobile queue registration. Dr. Ben Lerner recently joined the team as COO with an emphasis on leading The Back Company's growth using his franchise and high-growth experience after a 17-year tenure as founder and CEO of a large chiropractic franchisor and lifestyle company."

    "Finally, we've already completed the second cohort and initiated the third cohort of our Phase 1 clinical trial. We anticipate completing our third and final cohort during summer, 2022. Each of these milestones are part of IMAC Holdings' roadmap to helping consumers develop a personalized, affordable and engaging experience that guides users to better spinal health and physical function. There was demonstrable progress during 2021 to set up a springboard of growth for 2022."

    Results of Operations for the Twelve Months Ended December 31, 2021 Compared to the Twelve Months Ended December 31, 2020

    Total revenue increased 12% from 12.8 million in 2020 to $14.4 million in 2021. Total revenues increased $1.6 million due to a combination of acquisitions, same-store growth, and the opening of retail chiropractic clinics. The increase in operating expenses from $19.4 million in 2020 to $24.5 million in 2021 was driven by a combination of additional salaries and expenses related to acquisitions and The Back Space launch in 2021 as well as the $0.42 million reduction in expenses from grant funds in 2020, resulting in an increase in operating loss to $10.1 million versus a loss of $6.5 million in 2020.

    For the year ended December 31, 2021, the Company reported cash and cash equivalents of $7.1 million, compared with approximately $2.6 million as of December 31, 2020.

    About IMAC Holdings, Inc. 

    IMAC Holdings owns and manages health and wellness centers that deliver sports medicine, orthopedic, and life science therapies for movement restricting diseases. IMAC is comprised of three business segments: outpatient medical centers, The Back Space, and a clinical research division. With treatments to address the aging population, IMAC Holdings owns or manages more than 15 outpatient medical clinics and has partnered with several active and former professional athletes, including Ozzie Smith, David Price, Mike Ditka, and Tony Delk to promote a minimally invasive approach to sports medicine. IMAC's The Back Space retail spine health and wellness treatment centers deliver chiropractic care within Walmart locations. IMAC's research division is currently conducting a Phase I clinical trial evaluating a mesenchymal stem cell therapy candidate for bradykinesia due to Parkinson's disease. For more information visit www.imacholdings.com.

    ###

    Safe Harbor Statement

    This press release contains forward-looking statements. These forward-looking statements, and terms such as "anticipate," "expect," "believe," "may," "will," "should" or other comparable terms, are based largely on IMAC's expectations and are subject to a number of risks and uncertainties, certain of which are beyond IMAC's control. Actual results could differ materially from these forward-looking statements as a result of, among other factors, risks and uncertainties associated with its ability to maintain and grow its business, variability of operating results, its ability to maintain and enhance its brand, its development and introduction of new products and services, the successful integration of acquired companies, technologies and assets, marketing and other business development initiatives, competition in the industry, general government regulation, economic conditions, dependence on key personnel, the ability to attract, hire and retain personnel who possess the skills and experience necessary to meet customers' requirements, and its ability to protect its intellectual property. IMAC encourages you to review other factors that may affect its future results in its registration statement and in its other filings with the Securities and Exchange Commission. In light of these risks and uncertainties, there can be no assurance that the forward-looking information contained in this press release will in fact occur.

    IMAC Press Contact:

    Laura Fristoe

    [email protected]



    Primary Logo

    Get the next $IMAC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $IMAC

    DatePrice TargetRatingAnalyst
    8/19/2021$2.35 → $1.75Buy → Neutral
    National Alliance Securities
    More analyst ratings

    $IMAC
    SEC Filings

    View All

    SEC Form 10-Q filed by IMAC Holdings Inc.

    10-Q - IMAC Holdings, Inc. (0001729944) (Filer)

    11/14/22 5:25:58 PM ET
    $IMAC
    Medical Specialities
    Health Care

    SEC Form EFFECT filed by IMAC Holdings Inc.

    EFFECT - IMAC Holdings, Inc. (0001729944) (Filer)

    10/14/22 12:15:29 AM ET
    $IMAC
    Medical Specialities
    Health Care

    SEC Form S-3/A filed by IMAC Holdings Inc. (Amendment)

    S-3/A - IMAC Holdings, Inc. (0001729944) (Filer)

    10/7/22 5:01:30 PM ET
    $IMAC
    Medical Specialities
    Health Care

    $IMAC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    IMAC Holdings downgraded by National Alliance Securities with a new price target

    National Alliance Securities downgraded IMAC Holdings from Buy to Neutral and set a new price target of $1.75 from $2.35 previously

    8/19/21 11:40:11 AM ET
    $IMAC
    Medical Specialities
    Health Care

    $IMAC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4: Sucoff Cary was granted 100,000 shares, increasing direct ownership by 100% to 200,000 units

    4 - IMAC Holdings, Inc. (0001729944) (Issuer)

    10/20/22 4:30:33 PM ET
    $IMAC
    Medical Specialities
    Health Care

    SEC Form 4: Evans Maurice E. was granted 100,000 shares, increasing direct ownership by 89% to 212,420 units

    4 - IMAC Holdings, Inc. (0001729944) (Issuer)

    10/20/22 4:30:36 PM ET
    $IMAC
    Medical Specialities
    Health Care

    SEC Form 4: Pruitt Michael D was granted 100,000 shares and covered exercise/tax liability with 37,000 shares, increasing direct ownership by 62% to 164,250 units

    4 - IMAC Holdings, Inc. (0001729944) (Issuer)

    10/20/22 4:30:38 PM ET
    $IMAC
    Medical Specialities
    Health Care

    $IMAC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    IMAC Holdings, Inc. Announces NASDAQ Ticker Symbol Change from "IMAC" to "BACK"

    BRENTWOOD, Tenn., Aug. 03, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) ("IMAC" or the "Company"), will change its ticker symbol on the NASDAQ Stock Exchange from "IMAC" to "BACK" at the open of market trading on Monday, August 8, 2022. "IMAC Holdings has developed a continuum of care for optimal spinal health, from the chiropractic wellness centers at the BackSpace to the IMAC Regeneration Centers' medical doctors, nurse practitioners, and physical therapists delivering advanced and innovative medical intervention," said Jeffrey Ervin, IMAC's Chief Executive Officer. "The spine is your body's central support structure and we recognize its importance for your overall health

    8/3/22 9:22:00 AM ET
    $IMAC
    Medical Specialities
    Health Care

    IMAC Holdings Announces Exploration of Strategic Alternatives to Maximize Shareholder Value

    BRENTWOOD, Tenn., July 26, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) ("IMAC" or the "Company"), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, today announced that its board of directors has initiated an exploration of strategic alternatives. As part of this process, the board will consider a wide range of options for the company including, among other things, a potential merger, spin-off, sale, or other strategic transaction for one or more of its key business units or assets. "As our company continues to expand into complementary revenue streams, we believe

    7/26/22 9:15:00 AM ET
    $IMAC
    Medical Specialities
    Health Care

    The Back Company demonstrates strong Q2 growth

    The Back Space sequential quarter traffic increased over 100% BRENTWOOD, Tenn., June 30, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) ("IMAC" or the "Company"), today announces significant traffic growth for The Back Company. The Back Space retail chiropractic centers, located in select Walmart stores, generated over 100% visit growth compared to the first quarter. "Our team's effort is evident as we continue to improve systems to support our doctors that delivered over 6,500 visits this calendar quarter," said Jeff Ervin, Chief Executive Officer of IMAC. "The Back Space growth for the second quarter will be a springboard to material revenue during the second half of the y

    6/30/22 9:20:00 AM ET
    $IMAC
    Medical Specialities
    Health Care

    $IMAC
    Leadership Updates

    Live Leadership Updates

    View All

    IMAC Holdings Appoints Sheri Gardzina as Secretary, Chief Financial Officer

    BRENTWOOD, Tenn., Jan. 07, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, today announces the appointment of Sheri Gardzina, CPA as its Chief Financial Officer. To date, Ms. Gardzina has served as CFO in an interim capacity. “Sheri has been an excellent addition to our management team since joining the company and we are pleased to have her as our permanent Chief Financial Officer. She brings a wealth of financial and accounting experience to the company and I am excited to continue worki

    1/7/21 8:00:00 AM ET
    $IMAC
    Medical Specialities
    Health Care

    $IMAC
    Financials

    Live finance-specific insights

    View All

    IMAC Holdings Reports Third Quarter 2021 Financial Results and Provides Corporate Update

    BRENTWOOD, Tenn., Nov. 10, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (NASDAQ:IMAC) ("IMAC" or the "Company"), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, today announces financial results for the third quarter ended September 30, 2021. Financial Highlights from 3Q 2021 (all comparisons are with the quarter ended September 30, 2020, unless otherwise indicated): Total revenue was $3.49 million, compared with $3.48 millionTotal patient visits at IMAC Centers were up 10% to 43,451, compared to 39,345Net loss was $1.7 million, or a loss of $0.07 per share, compared with a net

    11/10/21 4:48:15 PM ET
    $IMAC
    Medical Specialities
    Health Care

    IMAC Holdings Reports Second Quarter 2021 Financial Results

    IMAC reports 36% increase in revenues and 70% increase in patient visits as it invests in value-generating assets BRENTWOOD, Tenn., Aug. 12, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (NASDAQ:IMAC) ("IMAC" or the "Company"), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, today announces financial results for the second quarter ended June 30, 2021. Financial Highlights from 2Q 2021 (all comparisons are for the quarter ended June 30, 2020, unless otherwise indicated): Total revenue was $3.4 million, compared with $2.5 million, an increase o

    8/12/21 9:00:00 AM ET
    $IMAC
    Medical Specialities
    Health Care

    IMAC Holdings Acquires Active Medical Center in Southwestern Chicago Suburb

    Naperville, Ill. purchase to be rebranded Mike Ditka IMAC Regeneration Center BRENTWOOD, Tenn., June 25, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) ("IMAC" or the "Company"), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, announces the Company's expansion in the Chicago market with the asset purchase of Active Medical Center's Naperville, Illinois location, effective Monday, June 28. Active Medical Center is a medical clinic that addresses a wide variety of orthopedic treatments for various conditions through a combination of medical and physical rehabilitatio

    6/25/21 8:00:00 AM ET
    $IMAC
    Medical Specialities
    Health Care

    $IMAC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by IMAC Holdings Inc.

    SC 13G - IMAC Holdings, Inc. (0001729944) (Subject)

    1/23/23 10:00:08 AM ET
    $IMAC
    Medical Specialities
    Health Care

    SEC Form SC 13G/A filed by IMAC Holdings Inc. (Amendment)

    SC 13G/A - IMAC Holdings, Inc. (0001729944) (Subject)

    9/9/22 4:05:20 PM ET
    $IMAC
    Medical Specialities
    Health Care

    SEC Form SC 13G filed by IMAC Holdings Inc.

    SC 13G - IMAC Holdings, Inc. (0001729944) (Subject)

    5/18/22 1:40:55 PM ET
    $IMAC
    Medical Specialities
    Health Care